APSR2026-257

 
Late-Breaking
Submitted
Poster Presentation
 
AP14-035
P54
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1211848-46904-APSR Poster CARCINOID Final for submission_428866.pdf
Format: PDF Only
08. Lung Cancer
4

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Hemalatha Munusamy * Hospital Melaka respiratory Melaka Malaysia
Khai Lip Ng - Hospital Melaka respiratory Melaka Malaysia
Nur Husna Mohd Aminudin - Hospital Melaka respiratory Melaka Malaysia
Hasmah Hashim - Hospital Melaka respiratory Melaka Malaysia
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Hemalatha
Munusamy
drhemalatha@hsi.gov.my
+60149386828
41-50
Malaysia
Case Report
The Silent Intruder: A 5-Year Endobronchial Mass Revealed as Carcinoid Tumour
Maximum 25 words
Abstract Content
 
 
 
 
Bronchial carcinoids are rare neuroendocrine tumors, representing <5% of bronchopulmonary neoplasms. Pulmonary neuroendocrine tumors include typical carcinoids, atypical carcinoids, small cell carcinomas, and large-cell neuroendocrine carcinomas, with typical carcinoids comprising 80–90% of cases. Clinical presentation can be atypical, making early recognition critical for diagnosis and prognosis. Radiological imaging, including chest X-ray and CT, identifies lesions and lobar collapse, while bronchoscopy allows direct visualization and biopsy. Histopathology with immunohistochemistry for chromogranin A and synaptophysin confirms diagnosis. Surgical resection is the mainstay of treatment, providing excellent long-term outcomes, particularly for typical carcinoids, while atypical variants carry higher recurrence risk.
We report a 55-year-old male smoker with a five-year history of intermittent cough, without hemoptysis, weight loss, or constitutional symptoms. Examination was unremarkable except for reduced air entry over the left lung. Initial chest radiography revealed a left thoracic opacity; contrast-enhanced CT (CECT) showed a 2.6 × 4.0 × 4.7 cm left main bronchus mass causing complete obstruction and total left lung collapse, with mediastinal lymphadenopathy. The patient defaulted bronchoscopy but re-presented five years later with lower respiratory tract infection. Repeat CECT showed a stable endobronchial mass. Bronchoscopy revealed a fleshy obstructing tumor. Histopathology demonstrated nests and trabeculae of uniform cells with low mitotic activity, positive for chromogranin A and synaptophysin, confirming neuroendocrine differentiation. The final diagnosis was typical carcinoid tumor (NET Grade 1), and he was referred for oncology management.
Bronchial carcinoid tumours are rare, representing <2% of primary lung malignancies, with typical carcinoids accounting for 76–90% of cases. They affect both sexes equally and usually present in the fourth to fifth decades. Typical carcinoids have <2 mitoses per 2 mm² and no necrosis, while atypical carcinoids show higher mitotic activity and necrosis. Most are centrally located, causing bronchial obstruction with symptoms such as recurrent pneumonia, chest pain, wheezing, and hemoptysis. Diagnosis relies on contrast-enhanced CT, bronchoscopy, and histopathological confirmation. Surgery is the mainstay of treatment, with excellent outcomes; adjuvant chemo or radiotherapy has limited efficacy.
 
 
Yes
No
 
JPG or JPEG or PNG format ONLY
bronchiole carcinoid, histopathology, carcinoid tumour
maximum 3 keywords and no abbreviations, separated by commas
no disclosure
327